Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SHAMAN PHARMACETICALS - SHMN - U.S. OTC -- Ignore unavailable to you. Want to Upgrade?

To: Mike Jafari who wrote (12)	2/26/1998 11:16:00 PM
From: Cody Goebel	Read Replies (1) \| Respond to of 69

I'm posting here even though I'd rather see all posts congregate on just one thread per stock. Anyway, I too have held SHMN for about a year with nothing much to show for it. However, thats not why we should buy biotech stocks, hell they could go down by half and still be just as worthwhile to hold. Not until they say the drugs are either a go a no-go should you make a decision about getting out, and hell by that time the market has likely made it for you!